Aurobindo's latest bid comes on the heels of last month’s shot at Israeli drug maker Teva's UK product portfolio, where it was outbid by rival Intas Pharmaceuticals. Intas buys Teva's UK ...

PRNewswire Ahmedabad Gujarat [India] October 14 Accord BioPharma Inc the US specialty division of Intas Pharmaceuticals Ltd ...

The best logo maker helps you craft the right branding for your business - even if you've never designed a logo before. Our team of expert reviewers have tested the best free logo makers and the ...

The previous Paralympic logo incorporated the Tae-Geuk, which is a traditional Korean decorative motif. According to oriental philosophy, Tae-Geuk refers to the ultimate reality from which all things ...

Coriolis Pharma, a biopharma company specializing in R&D and GMP drug product development, recently announced the launch of a ...

India’s Intas Pharma, whose biosimilar is already approved in India and in a late-stage trial in the US, and Iran’s AryoGen Pharmed, which reported phase 3 results with its Arylia candidate in ...

Chris Rose of ProStrakan offers advice on selling in the pharmaceutical industry. The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use ...

The global pharmaceutical industry is growing and offers an attractive opportunity for investors. Well-established pharmaceutical stocks include AbbVie, Eli Lilly, Johnson & Johnson, and Pfizer.

Mayne Pharma Group (AU:MYX) has released an update. Insignia Financial Ltd has become a substantial shareholder in Mayne Pharma Group, holding ...

According to the EMA CHMP summary of positive opinion, DMB-3115 is highly similar to the reference product Stelara (ustekinumab) and has demonstrated comparable quality, safety and efficacy to Stelara ...

Learn about Intas Pharmaceuticals in Dehradun, Uttarakhand.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are ...

Intas Pharma becomes most valuable privately held pharma company A PE deal values Intas at Rs 23,000 crore or USD 3.5 billion, making it the most valued pharma privately held company in India.